OPERA I Archives - Medical Conferences

Long-term suppression of MRI disease activity with ocrelizumab

Presented By

Dr Douglas Arnold, McGill University, Canada

Trial

Phase 3, OPERA I/II, ORATORIO

Conference

ECTRIMS 2021

Type

Peer-reviewed article

9 December 2021 14:30

Presented By

Prof. Tobias Derfuss, University Hospital Basel, Switzerland

Conference

ECTRIMS 2019

Type

Peer-reviewed article

8 November 2019 19:23

Trial

OPERA I, OPERA II, TOSCA

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 18:53